Author: Advanced Ocular Care

News

Ocular Therapeutix Resubmits NDA For Dextenza
Ocular Therapeutix has resubmitted a new drug application (NDA) to the FDA for Dextenza (dexamethasone insert) 0.4 mg for the treatment of ocular pain occurring after ophthalmic surgery…